OSCC cells were lysed in RIPA buffer (pH 7.6, 50 mM Tris HCl, 300 mM NaCl, 0.5% Triton X-100, 2 μL/mL aprotinin) (Elpis-Biotech, Inc., Daejeon, Korea) mixed with 2 mM of PMSF and 2 μL/mL of leupeptin. The lysate was subjected to a Pierce BCA protein assay (ThermoFisher Scientific) for measuring the amount of protein, then separated in a SDS-PAGE gel and transferred onto nitrocellulose membranes (MilliporeSigma, Burlington, MA, USA), with the subsequent blocking step using 3% BSA. The primary antibodies used include: β-Actin, β-catenin, p-β-catenin, GSK3β, p-GSK3β (Santa Cruz Biotechnology, Dallas, TX, USA), Wntless (WLS) (Abcam, Cambridge, MA, USA) and Wnt3a (Cell Signaling Technology, Danvers, MA, USA). Chemiluminescence was detected using the WesternBrightTM ECL (Advansta Inc., San Jose, CA, USA) and WesternBrightTM Sirius kit (Advansta Inc.) together with the secondary antibody (Cell Signaling Technology). The signal intensity of each protein band was then quantified using a LAS 3000 (Fuji Photo Film Co., Ltd.).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.